Fewer foreign pharmaceuticals: Healthcare reform causes controversy
Our "China Perspective" column is written by authors from the People's Republic. There have been heated discussions about China's healthcare system. The government has severely restricted access to branded foreign drugs in public hospitals. However, many doubt the effectiveness of domestic generic alternatives.
LP
30. January 2025
30. January 2025
Last updated: 24. July 2025
Share article: